Home/Pipeline/Anxiety Disorders Biomarker Services

Anxiety Disorders Biomarker Services

Anxiety Disorders

Service OfferingActive

Key Facts

Indication

Anxiety Disorders

Phase

Service Offering

Status

Active

Company

The Siesta Group

About The Siesta Group

The Siesta Group is a Vienna-based, neuroscience-focused service provider that empowers CNS drug development through advanced analysis of EEG, sleep, and activity data. Leveraging over 20 years of experience, proprietary AI-powered analysis tools, and a strong scientific network, the company helps sponsors identify biomarkers and endpoints for conditions ranging from sleep disorders to neurodegenerative diseases. It operates as a trusted partner to over 30 leading sponsors and CROs, offering a full suite of clinical trial services from feasibility to data visualization, all while maintaining rigorous compliance standards.

View full company profile

Therapeutic Areas

Sleep Disorders Sleep Apnea Neurodegenerative Diseases Mood Disorders Schizophrenia Autism Anxiety Disorders

Other Anxiety Disorders Drugs

Drug	Company	Phase	Status
Anxiety Clinical Trials	Boston Clinical Trials	Not Specified (Typically Phase 2-3)	Active
GABA-A PAM for Anxiety	Modulate Bio	Discovery	Active
Supera-CBD	TNF Pharmaceuticals	Preclinical	Active
TLR-007	Tilray	Phase 1/2	Active
LYT-300	PureTech Health	Phase 1	Active
CTx-2103	Cingulate	Preclinical	Active